Adaptin Bio (APTN) Gains from Investment Securities (2024 - 2026)

Adaptin Bio has disclosed Gains from Investment Securities across 3 years of filings, most recently posting $17940.0 for Q2 2026.

• In Q2 2026, Gains from Investment Securities changed N/A year-over-year to $17940.0; the TTM figure through Jun 2026 stood at $1.5 million (up 6845.86% YoY), while the FY2025 annual figure was $6312.0, down 63.06% from the prior year.
• Gains from Investment Securities came in at $17940.0 for Q2 2026 at Adaptin Bio, down from $1.4 million in the prior quarter.
• In the past five years, Gains from Investment Securities ranged from a high of $1.4 million in Q1 2026 to a low of $133.0 in Q1 2024.
• Average Gains from Investment Securities over 3 years is $210656.9, with a median of $6312.0 recorded in 2025.
• Year-over-year, Gains from Investment Securities soared 4645.86% in 2025 and jumped 22606.89% in 2026.
• Over 3 years, Gains from Investment Securities stood at $8332.0 in 2024, then fell by 24.24% to $6312.0 in 2025, then jumped by 184.22% to $17940.0 in 2026.
• Per Business Quant data, the three most recent Gains from Investment Securities figures were $17940.0 in Q2 2026, $1.4 million in Q1 2026, and $6312.0 in Q1 2025.